Crestor reduces cardiovascular risk in some women, study says

11/30/2009 | Medscape (free registration)

Women with low LDL cholesterol and elevated high-sensitivity C-reactive protein levels cut in half their risk of cardiovascular events by taking rosuvastatin, or Crestor, according to the JUPITER study supported by AstraZeneca. The risk reduction was similar to that seen in men who participated in the trial.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Market Access Manager Electrophysiology HEOR (AEP) - 15000003NZ
Menlo Park, CA
Sales Manager, Employer Programs
PartnerRe Health